WHO ICTRP trial
The effect of vitamin D in Optic Neuritis outcome
IRCT201205319919N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201205319919N1 |
|---|---|
| Public title | The effect of vitamin D in Optic Neuritis outcome |
| Scientific title | The effect of vitamin D3 supplemenation in the prevention of Optic Neuritis conversion to Multiple Sclerosis in patients with low serum vitamin D status after one year follow up:a randomized double blind clinical trial. |
| Primary sponsor | Isfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Optic neuritis. Optic neuritis;Optic neuritis |
| Interventions | Intervention 1: Administration of vitamin D3 at a dosage of 50000IU/week in the form of oral pearls to treatment group for 12 months. Intervention 2: Administration of a similar pearl shape placebo to control group for 12 months.;Treatment… |
| Registration date | Jun 23, 2012 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: